VEGFR2/CD309 anticorps
Aperçu rapide pour VEGFR2/CD309 anticorps (ABIN2141992)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Purification
- Purified by affinity chromatography.
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
-
FC: ≤ 1 μg/test
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- In aqueous buffer with 0.09 % sodium azide, may contain carrier prote/stabilizer.
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8 °C. Do not freeze. Protect from light
-
-
-
: "The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." dans: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
: "VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis." dans: Developmental cell, Vol. 18, Issue 5, pp. 713-24, (2010) (PubMed).
-
: "The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." dans: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- Flk1
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-